Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

uniQure N.V. - Ordinary Shares (NQ:QURE)

42.91 -2.26 (-5.00%)
Streaming Delayed Price Updated: 10:51 AM EDT, Jul 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 710,257
Open 45.99
Bid (Size) 42.88 (1,200)
Ask (Size) 42.99 (400)
Prev. Close 45.17
Today's Range 42.88 - 46.09
52wk Range 8.730 - 71.50
Shares Outstanding 54,865,673
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
From uniQure Inc.
Via GlobeNewswire
News headline image
uniQure Announces Pricing of Upsized $225 Million Public Offering
From uniQure Inc.
Via GlobeNewswire

Performance

YTD
+83.5%
+83.5%
1 Month
+52.1%
+52.1%
3 Month
+154.1%
+154.1%
6 Month
+79.3%
+79.3%
1 Year
+206.7%
+206.7%

More News

Read More
News headline image
uniQure Announces $150 Million Proposed Public Offering
From uniQure Inc.
Via GlobeNewswire
News headline image
QURE Was Just the Beginning: 5 Biotech Catalysts I’m Watching Now ↗
Via InvestorPlace
News headline image
uniQure Announces Preliminary Data on the First Cohort in the Phase I/IIa Clinical Trial of AMT-260 in Refractory Mesial Temporal Lobe Epilepsy
From uniQure Inc.
Via GlobeNewswire
Top movers in Wednesday's session ↗
Via Chartmill
These stocks are moving in today's session ↗
Via Chartmill
Gapping stocks in Wednesday's session ↗
Via Chartmill
Discover the top movers in Wednesday's pre-market session. ↗
Via Chartmill
News headline image
uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease
From uniQure Inc.
Via GlobeNewswire
News headline image
uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates
From uniQure Inc.
Via GlobeNewswire
News headline image
uniQure Announces Successful UK MHRA Pre-Submission Meeting for AMT-130 in Huntington’s Disease
From uniQure Inc.
Via GlobeNewswire
News headline image
uniQure to Announce First Quarter 2026 Financial Results
From uniQure Inc.
Via GlobeNewswire
News headline image
QURE CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
uniQure N.V. 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against uniQure N.V. - QURE
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
QURE Deadline: Rosen Law Firm Urges uniQure N.V. (NASDAQ: QURE) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
UNIQURE DEADLINE MONDAY: Bragar Eagel & Squire, P.C. Encourages uniQure N.V. Stockholders with Large Losses to Contact the Firm Before April 13th
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V. - QURE
From SkyMedia, LLC
Via GlobeNewswire
News headline image
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in uniQure N.V. of Class Action Lawsuit and Upcoming Deadlines – QURE
From Pomerantz LLP
Via GlobeNewswire
News headline image
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against uniQure N.V.
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
UNIQURE N.V. (NASDAQ: QURE) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by April 13, 2026
From Berger Montague
Via GlobeNewswire

Frequently Asked Questions

Is uniQure N.V. - Ordinary Shares publicly traded?
Yes, uniQure N.V. - Ordinary Shares is publicly traded.
What exchange does uniQure N.V. - Ordinary Shares trade on?
uniQure N.V. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for uniQure N.V. - Ordinary Shares?
The ticker symbol for uniQure N.V. - Ordinary Shares is QURE on the Nasdaq Stock Market
What is the current price of uniQure N.V. - Ordinary Shares?
The current price of uniQure N.V. - Ordinary Shares is 42.91
When was uniQure N.V. - Ordinary Shares last traded?
The last trade of uniQure N.V. - Ordinary Shares was at 07/02/26 10:51 AM ET
What is the market capitalization of uniQure N.V. - Ordinary Shares?
The market capitalization of uniQure N.V. - Ordinary Shares is 2.35B
How many shares of uniQure N.V. - Ordinary Shares are outstanding?
uniQure N.V. - Ordinary Shares has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.